B站免费版入口,宝贝腿开大点我添添你,亚洲国产一区二区,99久久夜色精品国产亚洲AV卜

IR-825 CAS1558079-49-4 用于腫瘤光熱光動力治療-僅科研

西安瑞禧生物科技有限公司可以提供一種用于腫瘤癌癥細胞的光熱治療和光動力治療的近紅外熒光染料IR-825，該產品的吸收波長是810nm,發射波長是830nm,該產品的末端帶有羧基COOH活性基團可以參與反應連接其他分子，這個產品的造價要低于ICG-COOH，可以廣泛用于腫瘤的光熱治療。我公司制備的IR-825純度95.4%，可以溶解在二氯甲烷、甲醇、DMF、DMSO里。

特別說明：該產品僅僅用于科學研究，不用于人體及藥物開發

IR-825 from ruixibio is a near-infrared dye (NIR). IR-825, after encapsulated into nanoparticles may be useful for cancer photothermal and photodynamic therapy. IR-825 nanoparticles showed pH-dependent fluorescence emission and excellent near-infrared (NIR) irradiation of cancer cells targeted in vitro to provide cytotoxicity. IR-825 nanoparticles showed efficient tumor homing together with rapid renal excretion behaviors, as revealed by MR imaging and confirmed by biodistribution measurement. Notably, when irradiated with an 808 nm laser, tumors on mice with IR-825 nanoparticle injection are completely eliminated without recurrence within 60 days, demonstrating the high efficacy of photothermal therapy.

Certificate of Analysis

 

 

 

General properties:

 

Name：IR825

 

Molecular Weight：823.4 Dalton

 

Cat.#：R-H-6012

 

Lot.#： RM017172

 

Date of Analysis：2018.01.09

 

Recommended Retest date：2019.01.09

 

Stability： 12 months

 

Storage： -20°C in the dark

 

Structure

 

 

 

 

Items		Specification	Results
Appearance		solid	solid
1H NMR		Identical to the structure	Identical to the structure
Foreign Material		None	None
Purity by HPLC		＞95%	95.4%
Report Date: 2018.01.09

Attachment 1: HPLC

Attachment 2: MS